论文部分内容阅读
拜糖平(Acarbose)是德国拜尔公司(Bayer)研制的一种新型口服降糖药,为α-葡萄糖苷酶抑制剂,能抑制葡萄糖在肠道的降解,延缓小肠对葡萄糖的吸收,从而降低血糖,尤其是餐后的血糖水平,减低血糖波动。为观察其临床疗
Acarbose is a new oral hypoglycemic agent developed by Bayer in Germany. It is an α-glucosidase inhibitor, which can inhibit the degradation of glucose in the intestine and delay the absorption of glucose in the small intestine. Lower blood sugar, especially postprandial blood glucose levels, reduce blood sugar fluctuations. To observe its clinical treatment